212 related articles for article (PubMed ID: 21119366)
1. Less impact of adjuvant chemotherapy for stage I clear cell carcinoma of the ovary: a retrospective Japan Clear Cell Carcinoma Study.
Takano M; Sugiyama T; Yaegashi N; Sagae S; Kuzuya K; Udagawa Y; Tsuda H; Suzuki M; Kigawa J; Goto T; Tsuda H; Moriya T; Kikuchi Y
Int J Gynecol Cancer; 2010 Dec; 20(9):1506-10. PubMed ID: 21119366
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemotherapy for stage I clear cell carcinoma of the ovary: an analysis of fully staged patients.
Takada T; Iwase H; Iitsuka C; Nomura H; Sakamoto K; Omatsu K; Takeshima N; Takizawa K
Int J Gynecol Cancer; 2012 May; 22(4):573-8. PubMed ID: 22398705
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy for stage i ovarian clear cell carcinoma: is it necessary for stage IA?
Mizuno M; Kajiyama H; Shibata K; Mizuno K; Yamamuro O; Kawai M; Nakanishi T; Nagasaka T; Kikkawa F
Int J Gynecol Cancer; 2012 Sep; 22(7):1143-9. PubMed ID: 22801028
[TBL] [Abstract][Full Text] [Related]
4. Impact of surgical staging in stage I clear cell adenocarcinoma of the ovary.
Suzuki K; Takakura S; Saito M; Morikawa A; Suzuki J; Takahashi K; Nagata C; Yanaihara N; Tanabe H; Okamoto A
Int J Gynecol Cancer; 2014 Sep; 24(7):1181-9. PubMed ID: 25010038
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy with irinotecan hydrochloride and cisplatin for clear cell carcinoma of the ovary.
Takano M; Kikuchi Y; Yaegashi N; Suzuki M; Tsuda H; Sagae S; Udagawa Y; Kuzuya K; Kigawa J; Takeuchi S; Tsuda H; Moriya T; Sugiyama T
Oncol Rep; 2006 Dec; 16(6):1301-6. PubMed ID: 17089053
[TBL] [Abstract][Full Text] [Related]
6. Progression-free survival and overall survival of patients with clear cell carcinoma of the ovary treated with paclitaxel-carboplatin or irinotecan-cisplatin: retrospective analysis.
Takano M; Sugiyama T; Yaegashi N; Suzuki M; Tsuda H; Sagae S; Udagawa Y; Kuzuya K; Kigawa J; Takeuchi S; Tsuda H; Moriya T; Kikuchi Y
Int J Clin Oncol; 2007 Aug; 12(4):256-60. PubMed ID: 17701003
[TBL] [Abstract][Full Text] [Related]
7. Survival impact of adjuvant paclitaxel and carboplatin for early-stage ovarian clear-cell carcinoma with complete surgical staging.
Kajiyama H; Shibata K; Suzuki S; Ino K; Kawai M; Nagasaka T; Nawa A; Kikkawa F
Gynecol Obstet Invest; 2011; 72(4):252-6. PubMed ID: 22041903
[TBL] [Abstract][Full Text] [Related]
8. Three versus six cycles of adjuvant platinum-based chemotherapy in early stage clear cell ovarian carcinoma - A multi-institutional cohort.
Prendergast EN; Holzapfel M; Mueller JJ; Leitao MM; Gunderson CC; Moore KN; Erickson BK; Leath CA; Diaz Moore ES; Cohen JG; Walsh CS
Gynecol Oncol; 2017 Feb; 144(2):274-278. PubMed ID: 27979319
[TBL] [Abstract][Full Text] [Related]
9. Survival impact of capsule rupture in stage I clear cell carcinoma of the ovary in comparison with other histological types.
Higashi M; Kajiyama H; Shibata K; Mizuno M; Mizuno K; Hosono S; Kawai M; Nakanishi T; Nagasaka T; Kikkawa F
Gynecol Oncol; 2011 Dec; 123(3):474-8. PubMed ID: 21955484
[TBL] [Abstract][Full Text] [Related]
10. Is adjuvant chemotherapy beneficial for surgical stage I ovarian clear cell carcinoma?
Hogen L; Brar H; Covens A; Bassiouny D; Bernardini MQ; Gien LT; Ferguson SE; Vicus D
Gynecol Oncol; 2017 Oct; 147(1):54-60. PubMed ID: 28760368
[TBL] [Abstract][Full Text] [Related]
11. Impact of adjuvant chemotherapy for stage I ovarian carcinoma with intraoperative tumor capsule rupture.
Shimizu D; Sato N; Sato T; Makino K; Kito M; Shirasawa H; Kumagai J; Terada Y
J Obstet Gynaecol Res; 2015 Mar; 41(3):432-9. PubMed ID: 25330897
[TBL] [Abstract][Full Text] [Related]
12. Improved survival trends in platinum-resistant patients with advanced ovarian, fallopian or peritoneal cancer treated with first-line paclitaxel/platinum chemotherapy: the impact of novel agents.
Bamias A; Bamia C; Zagouri F; Kostouros E; Kakoyianni K; Rodolakis A; Vlahos G; Haidopoulos D; Thomakos N; Antsaklis A; Dimopoulos MA
Oncology; 2013; 84(3):158-65. PubMed ID: 23296063
[TBL] [Abstract][Full Text] [Related]
13. Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging.
Takano M; Kikuchi Y; Yaegashi N; Kuzuya K; Ueki M; Tsuda H; Suzuki M; Kigawa J; Takeuchi S; Tsuda H; Moriya T; Sugiyama T
Br J Cancer; 2006 May; 94(10):1369-74. PubMed ID: 16641903
[TBL] [Abstract][Full Text] [Related]
14. The impact of complete surgical staging upon survival in early-stage ovarian clear cell carcinoma: a multi-institutional retrospective study.
Takano M; Sugiyama T; Yaegashi N; Suzuki M; Tsuda H; Sagae S; Udagawa Y; Kuzuya K; Kigawa J; Takeuchi S; Tsuda H; Moriya T; Kikuchi Y
Int J Gynecol Cancer; 2009 Nov; 19(8):1353-7. PubMed ID: 20009889
[TBL] [Abstract][Full Text] [Related]
15. Low response rate of second-line chemotherapy for recurrent or refractory clear cell carcinoma of the ovary: a retrospective Japan Clear Cell Carcinoma Study.
Takano M; Sugiyama T; Yaegashi N; Sakuma M; Suzuki M; Saga Y; Kuzuya K; Kigawa J; Shimada M; Tsuda H; Moriya T; Yoshizaki A; Kita T; Kikuchi Y
Int J Gynecol Cancer; 2008; 18(5):937-42. PubMed ID: 18081792
[TBL] [Abstract][Full Text] [Related]
16. Prognostic implication of endometriosis in clear cell carcinoma of the ovary.
Orezzoli JP; Russell AH; Oliva E; Del Carmen MG; Eichhorn J; Fuller AF
Gynecol Oncol; 2008 Sep; 110(3):336-44. PubMed ID: 18639330
[TBL] [Abstract][Full Text] [Related]
17. The association between timing of initiation of adjuvant therapy and the survival of early stage ovarian cancer patients - An analysis of NRG Oncology/Gynecologic Oncology Group trials.
Chan JK; Java JJ; Fuh K; Monk BJ; Kapp DS; Herzog T; Bell J; Young R
Gynecol Oncol; 2016 Dec; 143(3):490-495. PubMed ID: 27771168
[TBL] [Abstract][Full Text] [Related]
18. Survival analysis of ovarian clear cell carcinoma confined to the ovary with or without comprehensive surgical staging.
Takano M; Sasaki N; Kita T; Kudoh K; Fujii K; Yoshikawa T; Kato M; Hirata J; Furuya K; Tsuda H; Kikuchi Y
Oncol Rep; 2008 May; 19(5):1259-64. PubMed ID: 18425385
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of lymph node metastasis and clear cell histology in ovarian carcinoma limited to the pelvis (pT1M0 and pT2M0).
Sakuragi N; Yamada H; Oikawa M; Okuyama K; Fujino T; Sagawa T; Fujimoto S
Gynecol Oncol; 2000 Nov; 79(2):251-5. PubMed ID: 11063653
[TBL] [Abstract][Full Text] [Related]
20. Clear cell carcinoma of the ovary: is there a role of histology-specific treatment?
Takano M; Tsuda H; Sugiyama T
J Exp Clin Cancer Res; 2012 Jun; 31(1):53. PubMed ID: 22655678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
